US 10472419
Prior Art
How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint
Patents that US 10472419 cites as prior art — the earlier inventions that this patent builds upon or distinguishes itself from.
CITED PATENTS
493
IN PATENTLENS
0
Citation data
This patent cites 493 prior patents. Citation detail pages are being built out in Phase 2.
Prior art citations are sourced from the USPTO patent database. Only patents indexed in PatentBrief are shown as links — others are recorded by number only.